Back to Multi-Omics Hub

Metabolomics Platform

Comprehensive small molecule metabolite profiling for disease biomarkers, pathway analysis, and drug metabolism studies

Metabolites Profiled

2,500+

Pathways Analyzed

150+

Biomarker Panels

50+

Clinical Studies

1,200+

Metabolomics: The Functional Readout of Cellular State

Metabolomics provides a comprehensive snapshot of small molecule metabolites (50-1500 Da), reflecting the integrated response to genetic, transcriptomic, proteomic, and environmental factors. As the functional endpoint closest to phenotype, metabolomics reveals real-time biochemical activity.

Technology Platforms

  • Mass Spectrometry (LC-MS/GC-MS): High-resolution untargeted/targeted profiling
  • NMR Spectroscopy: Non-destructive, quantitative metabolite identification
  • Targeted Assays: Clinical chemistry panels for specific metabolites

Key Applications

  • Disease Biomarkers: Diabetes, cancer, CVD, neurodegeneration
  • Drug Metabolism: Pharmacokinetics, drug-drug interactions, toxicity
  • Precision Nutrition: Personalized diet recommendations, microbiome effects

Metabolomics Workflow

1

Sample Collection

Blood, urine, tissue, cells - rapid quenching

2

Metabolite Extraction

Solvent extraction, derivatization

3

Analytical Profiling

LC-MS, GC-MS, NMR analysis

4

Data Integration

Pathway enrichment, multi-omics

AI-Powered Identification

Machine learning for metabolite identification from MS/MS spectra using spectral libraries and in silico prediction

Pathway Enrichment

Automated enrichment analysis using KEGG, Reactome, and MetaCyc to identify dysregulated metabolic pathways

Clinical Translation

Validated biomarker panels for clinical diagnostics, treatment monitoring, and precision medicine